Osamu Taguchi
Matsusaka, 5158544, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Skeletal Muscle Mass Estimation from Lower Leg Digital Images Using Machine Learning.
Journal: Progress in rehabilitation medicine
Published: October 21, 2025
A Behaviourally Anchored Checklist for Mental Health Occupational Therapy Intake Interviews: Development and Reliability in a Single-Station Standardised Patient Encounter.
Journal: Perspectives on medical education
Published: July 30, 2025
Pathogen detection by multiplex PCR: A comparative study of pneumonia panel, bacterial culture, and respiratory panel in Japanese patients.
Journal: Respiratory investigation
Published: March 14, 2025
Suitability of Specimens from Pleural Dissemination of Non-Small Cell Lung Cancer for Genetic Testing Using Forceps and Cryobiopsy.
Journal: Respiration; international review of thoracic diseases
Published: December 10, 2024
Intrinsic impacts of the expression of PD-L1 on postoperative recurrence in EGFR-mutated lung adenocarcinoma.
Journal: Frontiers in oncology
Published: April 11, 2024
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma.
Journal: Anticancer research
Published: August 10, 2023
Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions.
Journal: Scientific reports
Published: June 01, 2023
Physical Activity Estimated by the Wearable Device in Lung Disease Patients: Exploratory Analyses of Prospective Observational Study.
Journal: Journal of clinical medicine
Published: June 01, 2023
Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation.
Journal: Scientific reports
Published: March 30, 2023
Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 14, 2022
Last Updated: 09/26/2026